These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7930473)

  • 1. A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group.
    Zarski JP; Causse X; Cohard M; Cougnard J; Trepo C
    J Hepatol; 1994 Jun; 20(6):735-41. PubMed ID: 7930473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis.
    Perez V; Tanno H; Villamil F; Fay O
    J Hepatol; 1990; 11 Suppl 1():S113-7. PubMed ID: 2079567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
    Vajro P; Tedesco M; Fontanella A; De Vincenzo A; Vecchione R; Ammendola R; Terracciano LM; Novissimo A; Vegnente A
    Pediatr Infect Dis J; 1996 Mar; 15(3):223-31. PubMed ID: 8852910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.
    Perez V; Findor J; Tanno H; Sordá J
    Gut; 1993; 34(2 Suppl):S91-4. PubMed ID: 8314497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
    J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents].
    Castañeda Guillot C; Escobar Capote MD; García Bacallao E; Borbolla Bousquets E
    G E N; 1994; 48(4):219-25. PubMed ID: 7557276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B.
    Helvaci M; Kizilgunesler A; Kasirga E; Ozbal E; Kuzu M; Sozen G
    J Gastroenterol Hepatol; 2004 Jul; 19(7):785-91. PubMed ID: 15209626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.
    Lok AS; Wu PC; Lai CL; Lau JY; Leung EK; Wong LS; Ma OC; Lauder IJ; Ng CP; Chung HT
    Gastroenterology; 1992 Jun; 102(6):2091-7. PubMed ID: 1587429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: a randomized controlled trial.
    Sarin SK; Guptan RC; Thakur V; Malhotra S; Malhotra V; Banerjee K; Khandekar P
    J Hepatol; 1996 Apr; 24(4):391-6. PubMed ID: 8738724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study.
    Fevery J; Elewaut A; Michielsen P; Nevens F; Van Eyken P; Adler M; Desmet V
    J Hepatol; 1990; 11 Suppl 1():S108-12. PubMed ID: 2079566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM anti-preS2 monitoring during combined corticosteroid/interferon-alpha 2b therapy in chronic hepatitis B.
    Fei GZ; Sylvan SP; Hellström UB; Yao GB
    Liver; 1991 Dec; 11(6):358-64. PubMed ID: 1779715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
    Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE
    S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
    Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.